Syngenta files for Hong Kong IPO, targets at least $5 billion: sources

• The deal could raise between $5-10 billion, making it Hong Kong's biggest IPO since 2010 according to LSEG data
• Hong Kong's IPO market has raised $45.8 billion year-to-date versus $24 billion in the same period last year, showing strong momentum
• Syngenta reported Q2 sales decline of 7% to $5.7 billion and EBITDA drop of 2% to $1 billion following exit from low-margin China business

Summary: Syngenta Hong Kong IPO Filing

Key Development:

Syngenta Group, the Swiss agrichemicals and seeds company, has confidentially filed for a Hong Kong IPO targeting at least $5 billion, with potential to reach $10 billion depending on market response. At maximum size, this would be Hong Kong's largest IPO since 2010.

Timeline:

The offering is expected to launch by end of 2026 or early 2027. This revives efforts by parent company Sinochem, a Chinese state-owned entity, after withdrawing a planned Shanghai listing in 2024.

Company Profile:

• Basel-based global farming company serving over 90 countries
• Employs more than 50,000 people
• Products include seeds, herbicides, insecticides, fungicides, and digital farming solutions

Recent Financial Performance:

Q2 results showed challenges following exit from low-margin Chinese business:

• Sales declined 7% to $5.7 billion
• EBITDA fell 2% to $1 billion (though up 4% on currency-adjusted basis)

Leadership Change:

Hengde Qin assumed CEO role effective August 1, 2026, replacing Jeff Rowe.

Market Context:

Hong Kong's IPO market is experiencing strong momentum, with $45.8 billion raised year-to-date versus $24 billion in the same period last year, according to LSEG data.

Status:

Final timing, offering size, and valuation remain undetermined. Both Syngenta and Sinochem declined to comment on the confidential filing.

Market Implications:

This mega-deal could further strengthen Hong Kong's position as a leading IPO destination and provide investors access to a major global agricultural technology player with significant emerging market exposure.